3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
9
Pancreatic Neoplasms
8
Rectal Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Colonic Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Clinical Stage I Gastric Cancer AJCC v8
2
Cholangiocarcinoma
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Uterine Neoplasms
1
Tongue Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Peritoneal Neoplasms
1
Paranasal Sinus Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Adenocarcinoma
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Small Intestinal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Interventions
pembrolizumab
96
Carboplatin
67
Paclitaxel
56
Cyclophosphamide
40
Capecitabine
30
Specimen Handling
28
sacituzumab govitecan
25
130-nm albumin-bound paclitaxel
24
Gemcitabine
22
Magnetic Resonance Spectroscopy
21
Doxorubicin
20
olaparib
19
Taxes
19
Biopsy
19
Albumin-Bound Paclitaxel
19
Drug Therapy
16
atezolizumab
13
Nivolumab
13
toripalimab
12
Radiotherapy
12
Epirubicin
12
durvalumab
11
Docetaxel
10
Cisplatin
10
Bevacizumab
10
eribulin
9
fludarabine
8
Standard of Care
7
Radiation
7
Injections
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
dehydroftorafur
×
1 year
×
Clear all
No trials found.